Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00891527 · ClinicalTrials.gov registry record · Phase 1
Pilot Study Using Avastin and Gleevec to Treat the Progression of Intraluminal Pulmonary Vein Stenosis
A Phase 1 study, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- Phase 1
- Development phase
- 50
- Enrollment target
NCT00891527 is a Phase 1 study that has completed, run by Boston Children's Hospital. The registered enrollment target is 50 participants.
The verdict
NCT00891527, a Phase 1 study, has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 50 participants
- Enrollment target
Study Summary
The objective of this study is to conduct a pilot study using biologic agents Avastin and Gleevec to treat progression of multivessel intraluminal pulmonary vein stenosis in children.
Interventions
- DRUG Bevacizumab (Avastin) and Imatinib Mesylate (Gleevec)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2008-10 |
| Est. Completion | 2015-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00891527
The ClinicalTrials.gov registry entry for NCT00891527 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bevacizumab (Avastin) and Imatinib Mesylate (Gleevec) is the first listed.
NCT00891527 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00891527 about?
NCT00891527 is a clinical study titled "Pilot Study Using Avastin and Gleevec to Treat the Progression of Intraluminal Pulmonary Vein Stenosis". The objective of this study is to conduct a pilot study using biologic agents Avastin and Gleevec to treat progression of multivessel intraluminal pulmonary vein stenosis in children.
What is the current status of trial NCT00891527?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 50 participants. The study started on 2008-10. Estimated completion is 2015-12.
What interventions are being tested in trial NCT00891527?
The interventions under investigation include: Bevacizumab (Avastin) and Imatinib Mesylate (Gleevec) (DRUG).
Who is sponsoring clinical trial NCT00891527?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.